Zobrazeno 1 - 10
of 308
pro vyhledávání: '"F Baudo"'
Autor:
Luca Spiezia, Sofia Barbar, Ezio Zanon, Graziella Saggiorato, Marta Milan, F. Baudo, Paolo Simioni, Barbara Brandolin
Publikováno v:
Haemophilia. 19:e50-e53
Haemostatic control is the first priority in acquired haemophilia A (AHA) and recent consensus recommendations suggest using bypassing agents (BAs) (recombinant activated FVII (rFVIIa) and activated prothrombin complex concentrate) as first-line trea
Publikováno v:
Haemophilia. 16:102-106
Summary. Acquired haemophilia (AH) is an autoimmune syndrome characterized by acute bleeding in patients with negative family and personal history, and factor VIII depletion. Its incidence is 1.6 × 106 population per year. AH is associated with auto
Publikováno v:
Scandinavian Journal of Haematology. 33:171-176
UNLABELLED A 73-year-old man with lung squamous-cell carcinoma simultaneously developed a factor VIII:C inhibitor and a transient positive direct Coombs' test. The factor VIII:C inhibitor was characterized as a mixture of IgG1, IgG2, IgG4 with kappa
Autor:
Alberto Tosetto, E. Tiraferri, Maurizio Molinatti, Angelo Ghirarduzzi, Daniela Poli, Enrica Morra, F. Baudo, Vittorio Pengo, G. Mostarda, F. de Cataldo
Publikováno v:
Internal and Emergency Medicine. 2:280-284
In the perioperative management of patients on long-term oral anticoagulant (OAC) therapy the problem is balancing the thromboembolic (TER) and the haemorrhagic risk (HR) in the perioperative period. The Federazione Centri per la diagnosi della tromb
Publikováno v:
Journal of Thrombosis and Haemostasis. 3:2684-2688
Summary. Background: VWF:RCo assay is the standard and widely used laboratory test for von Willebrand disease (VWD) diagnosis. It is hampered by high intra- and inter-assay imprecision and is time consuming. Automation may improve the assay performan
Autor:
de Cataldo F, F. Baudo
Publikováno v:
BJOG: An International Journal of Obstetrics and Gynaecology. 110:311-314
OBJECTIVE To review the clinical problems related to the inhibitor of factor VIII (FVIII) in pregnancy. DESIGN Retrospective analysis. SETTING Haemophilia and haemotology centres. POPULATION Patients registered and followed up at the centres. METHODS
Autor:
Alessandro Gringeri, Elena Santagostino, F. A. Scaraggi, F. Baudo, Angiola Rocino, Massimo Morfini
Publikováno v:
Thrombosis and Haemostasis. 86:954-958
SummaryA multicenter prospective study of recombinant activated factor VII (rFVIIa) given by continuous infusion (CI) to treat severe hemorrhages and to handle surgical procedures was carried out.Relations between clinical efficacy, dosages used and
Autor:
Cristina Legnani, S. Arlati, A. Ravizza, Armando D'Angelo, G. Casella, L. Ridolfi, F. Baudo, Giliola Calori, D. Giudici, G. Palareti, T M Caimi, G. Gallioli, R. Rossi, L. Crippa, D. Carugo, F. deCataldo, A. Wolfler
Publikováno v:
Intensive Care Medicine. 24:336-342
ATIII is decreased in sepsis and/or shock and its baseline value correlates with mortality. The efficacy of ATIII therapy on mortality was assessed in a selected group of patients admitted to the intensive care unit (ICU) in a double-blind, randomize
Autor:
Robert D. Rosenberg, Elena Santagostino, Pier Mannuccio Mannucci, Kenneth A. Bauer, G Tagariello, F Baudo, A Gringeri
Publikováno v:
Thrombosis and Haemostasis. 71:737-740
SummaryPurer factor IX (FIX) concentrates have been produced for the treatment of hemophilia B in the attempt to reduce the risk of thrombotic complications associated with the use of prothrombin complex concentrates. To evaluate ex vivo whether or n
Autor:
Francesco Bernardi, Giovanna Marchetti, Donato Gemmati, P. Arcieri, M. Papacchini, P. Patracchini, F. Baudo, R. Redaelli, M. Ferrati, G. Mariani
Publikováno v:
Human Genetics. 92:446-450
Molecular defects and polymorphic haplotypes of coagulation factor VII gene were studied in eight unrelated Italian subjects with factor VII deficiency, seven having the factor VII- variant, one the factor VIIR variant. An intron 7 mutation, which al